Strategic Owner’s Rep | $1B+ BioPharma Portfolio
Elite Oversight & Programmatic Safety Leadership for Life Science Capital Projects
Strategic Owner’s Rep | $1B+ BioPharma Portfolio
Elite Oversight & Programmatic Safety Leadership for Life Science Capital Projects